Literature DB >> 21156240

6p21 rearrangements in uterine leiomyomas targeting HMGA1.

Maliheh Hashemi Nezhad1, Norbert Drieschner, Sabrina Helms, Anke Meyer, Mahboobeh Tadayyon, Markus Klemke, Gazanfer Belge, Sabine Bartnitzke, Käte Burchardt, Christiane Frantzen, Ernst Heinrich Schmidt, Jörn Bullerdiek.   

Abstract

To quantify the expression of HMGA1 mRNA in uterine leiomyomas, the expression of HMGA1 was analyzed in a series including tumors with aberrations of chromosome 6 (n = 7) and cytogenetically normal tumors (n = 8) as a control group by quantitative reverse transcriptase-polymerase chain reaction. The average expression level in the 6p21 group was found to be 5.6 times higher than that in the control group, and with one exception, all cases with 6p21 alteration revealed a high expression of HMGA1 mRNA than cytogenetically normal tumors. Nevertheless, compared to fibroids with a normal karyotype, the upregulation of the HMGA1 mRNA in these cases was much less strong than that of HMGA2 mRNA in case of 12q14∼15 aberrations identified in previous studies.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21156240     DOI: 10.1016/j.cancergencyto.2010.08.005

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  13 in total

1.  A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality.

Authors:  Ioannis Panagopoulos; Kristin Andersen; Ludmila Gorunova; Ben Davidson; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Sep-Oct       Impact factor: 3.395

2.  HMGA1 interacts with β-catenin to positively regulate Wnt/β-catenin signaling in colorectal cancer cells.

Authors:  Junjie Xing; Guangwen Cao; Chuangang Fu
Journal:  Pathol Oncol Res       Date:  2014-04-03       Impact factor: 3.201

3.  Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas.

Authors:  Min Ju Park; Hailian Shen; Nam Hee Kim; Fangjian Gao; Courtney Failor; Jennifer F Knudtson; Jessica McLaughlin; Sunil K Halder; Tuomas A Heikkinen; Pia Vahteristo; Ayman Al-Hendy; Robert S Schenken; Thomas G Boyer
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

4.  Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.

Authors:  Miika Mehine; Eevi Kaasinen; Hanna-Riikka Heinonen; Netta Mäkinen; Kati Kämpjärvi; Nanna Sarvilinna; Mervi Aavikko; Anna Vähärautio; Annukka Pasanen; Ralf Bützow; Oskari Heikinheimo; Jari Sjöberg; Esa Pitkänen; Pia Vahteristo; Lauri A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

Review 5.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

Review 6.  Vascular biology of uterine fibroids: connecting fibroids and vascular disorders.

Authors:  Gregory W Kirschen; Abdelrahman AlAshqar; Mariko Miyashita-Ishiwata; Lauren Reschke; Malak El Sabeh; Mostafa A Borahay
Journal:  Reproduction       Date:  2021-07-08       Impact factor: 3.923

7.  Novel KAT6B-KANSL1 fusion gene identified by RNA sequencing in retroperitoneal leiomyoma with t(10;17)(q22;q21).

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Bodil Bjerkehagen; Sverre Heim
Journal:  PLoS One       Date:  2015-01-26       Impact factor: 3.240

8.  Genetic heterogeneity in leiomyomas of deep soft tissue.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Marta Brunetti; Antonio Agostini; Hege Kilen Andersen; Ingvild Lobmaier; Bodil Bjerkehagen; Sverre Heim
Journal:  Oncotarget       Date:  2017-07-25

9.  Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21).

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Bodil Bjerkehagen; Ingvild Lobmaier; Sverre Heim
Journal:  Int J Oncol       Date:  2015-12-28       Impact factor: 5.650

10.  LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.

Authors:  Wensheng Zhang; Yigang Lu; Huibo Shi; Xungang Li; Zhuo Zhang; Xinxi Deng; Yang Yang; Bin Wan
Journal:  Hum Cell       Date:  2021-06-25       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.